Business Wire

Winners Announced in Prestigious GCCA Photo Competition Which Highlights Beauty and Essential Role of Concrete Throughout World

Share

A stunning image of a skateboard park in the United Arab Emirates has been named Concrete in Life Photo of the Year. It wins a top prize of $10,000 (ten thousand US dollars) in a global competition, which highlights the essential role that concrete plays around the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230215005136/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Ferdz Bedana, winner Urban Concrete Professional and overall winner, Concrete in Life Photo of Year. Location Sharjah, UAE

The photo, taken by professional photographer, Ferdz Bedana, in Sharjah, was announced as the overall winner in a live Instagram broadcast, on 15th February. It was selected from more than 14,000 photos submitted by both amateur and professional photographers from every continent, in the annual competition run by the Global Cement and Concrete Association.

Thomas Guillot, GCCA Chief Executive said: “Concrete is the second most used substance on earth after water and plays a vital part in modern infrastructure and society. Through the work of the GCCA and our members, to implement our 2050 Net Zero Roadmap, we are working hard and making progress in reducing its environmental impact. These amazing photos capture the appeal of concrete design and the essential role it plays in modern life and communities everywhere.”

Entrants from around the world submitted photos across four categories: concrete infrastructure, concrete beauty and design, urban concrete, and concrete in daily life, with each section divided between professional photographers and amateurs, often with smart phones. The breadth and variety of all the entries highlight the way concrete supports life around the world, from the giant to the small form, as well as the material’s grace, beauty and crucial supporting role.

Eight category winners each receive a prize of $2,500 (two thousand, five hundred US dollars) each. As well as Ferdz Bedana’s skateboarder image, the category winners include images of a waterfall and a roller-skater race, both taken in Indonesia, a stunning city interchange in China, rice mills in Bangladesh, a university building in Mexico, a metro station in Dubai and a Mosque in Istanbul, Turkey.

Ferdz Bedana who took the overall Concrete in Life Photo of Year in Sharjah, said: “It’s a great honour to be the overall winner of the Concrete in Life 2022 competition and spread the story of how concrete is a big contribution in our life. I was interested to take a photo of this skatepark when I saw a boy enjoying playing in a substantially artistic concrete design.”

Chris George, Content Director at Digital Camera World, and one of the competition judges said about the winning photo: “This was an amazing capture, that perfectly shows the energy of skateboarding against the organic form of the manmade structure.”

Fellow judge, freelance writer and photographer Norman Miller added: “It’s a real skill to capture fast moving subject while showing mastery of framing and control of lighting.”

Thomas Guillot, GCCA Chief Executive added: “Congratulations to Ferdz Bedana and all our category winners. Check out our website to see all the shortlisted entries who were all outstanding.”

The GCCA and its member companies, which account for 80% of global cement production capacity outside of China, as well as key Chinese manufacturers, are committed to reducing and eliminating CO2 emissions through implementation of the Concrete Future - 2050 Net Zero Roadmap – the first heavy industry to set out such a detailed plan.

Notes to editors:

Images available for media to use here .

Video of Instagram broadcast announcing winners available here .

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further details, or interview requests:
Simon Thomson, Head of Media, GCCA
simon.thomson@gccassociation.org / +44 7380 972282

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA ™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical Oncology Congress 202518.10.2025 14:00:00 EEST | Press release

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of vimseltinib in patients with TGCT in cases where surgical removal of the tumor is not an option will be presented as a poster during the 2025 European Society for Medical Oncology Congress (ESMO), taking place October 17-21 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251018921529/en/ “These long-term Phase 3 MOTION results add to the established body of evidence supporting vimseltinib as a best-in-class treatment for TGCT,” said Matthew L. Sherman, M.D., Chief Medical Officer of Deciphera. “TGCT often causes debilitating pain, stiffness and impaired mobility and these results demonstrate the durable benefit that vimseltinib can offer patients.” Summary of Data and Findings from the 2-year results of the MOTION Phase

ProAmpac Acquires International Paper’s Bag Converting Operations17.10.2025 17:09:00 EEST | Press release

ProAmpac, a global leader in flexible packaging and material science, has acquired the bag converting operations of International Paper (“IP”), a global leader in sustainable packaging. The acquisition expands ProAmpac’s converting capabilities, further advancing the company’s Fiberization of Packaging® strategy and enhancing its ability to deliver customized bag solutions for the grocery, convenience store, and quick-service restaurant markets. “Global demand for reliable, recyclable paper packaging continues to grow rapidly amid evolving consumer expectations and market trends redefining recyclability,” stated Greg Tucker, ProAmpac founder, vice chairman, and chief executive officer. “ProAmpac’s acquisition of IP’s bag operation supports our Fiberization of Packaging initiatives, helping us better serve customers by extending our expertise in material science to the US west coast with additional capabilities and redundancies,” continued Tucker. “IP’s bag business is strong, being bui

Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT17.10.2025 17:00:00 EEST | Press release

Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimulating factor-1 receptor (CSF-1R) inhibitor in development by Abbisko Therapeutics Co., Ltd., for the treatment of patients with tenosynovial giant cell tumor (TGCT). This latest analysis showed that, with a median follow-up of 14.3 months, the objective response rate (ORR) for people treated with pimicotinib from the beginning of the study increased considerably to 76.2% (95% CI: 63.8, 86.0) by blinded independent review committee (BICR) per RECIST v1.1, from 54% at Week 25. The study also showed continued clinically meaningful improvements in key secondary endpoints related to patient outcomes such as pain and function. The safety profile was consistent with previously reported data. The results are being presented today in the Sarcoma mini-oral session at the European Society for Medical

Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week17.10.2025 16:04:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B cell-mediated diseases. Pove is the only BAFF+APRIL inhibitor in pivotal trials for multiple kidney diseases. Next Steps for Pove Development In IgAN Following the announcement that the Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) to pove for the treatment of IgAN, FDA recently granted a rolling review of the Biologics License Application (BLA) for pove for this indication. Vertex expects to submit the first module to FDA for potential accelerated approval before t

Qualcomm Announces Quarterly Cash Dividend17.10.2025 16:00:00 EEST | Press release

Qualcomm Incorporated (NASDAQ: QCOM) today announced a quarterly cash dividend of $0.89 per common share, payable on December 18, 2025, to stockholders of record at the close of business on December 4, 2025. About Qualcomm Qualcomm relentlessly innovates to deliver intelligent computing everywhere, helping the world tackle some of its most important challenges. Building on our 40 years of technology leadership in creating era-defining breakthroughs, we deliver a broad portfolio of solutions built with our leading-edge AI, high-performance, low-power computing, and unrivaled connectivity. Our Snapdragon® platforms power extraordinary consumer experiences, and our Qualcomm Dragonwing™ products empower businesses and industries to scale to new heights. Together with our ecosystem partners, we enable next-generation digital transformation to enrich lives, improve businesses, and advance societies. At Qualcomm, we are engineering human progress. Qualcomm Incorporated includes our licensing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye